In Vietnam, eight state-owned pharma companies are expected to go public this year. Vinapharm – which is expected to have a strong investor response- along with Central Pharmacy 1, Central Pharmacy 2, Vietnam Medical Equipment and DK Pharma (established by the Hanoi University of Pharmacy) are slated for their initial public offerings (IPO) in the second quarter.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
